$18.34
-0.32 (-1.71%)
Regeneron Pharmaceuticals, Inc. (REGN)
CAPS Rating:
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

RSS Headlines
Fool UK